EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Ascorbate insufficiency disrupts glutamatergic signaling and alters electroencephalogram phenotypes in a mouse model of Alzheimer's disease

Rebecca A Buchanan, Yuhan Wang, James M May, Fiona E Harrison

Neurobiology of Disease · 2024

DOI: 10.1016/j.nbd.2024.106602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2024. Verfasst von Rebecca A Buchanan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, United States. Hauptthemen laut MEDLINE: Alzheimer Disease, Disease Models, Animal, Electroencephalography, Ascorbic Acid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, Health Services Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical studies have reported that increased epileptiform and subclinical epileptiform activity can be detected in many patients with an Alzheimer's disease (AD) diagnosis using electroencephalogram (EEG) and this may correlate with poorer cognition. Ascorbate may have a specific role as a neuromodulator in AD as it is released concomitantly with glutamate reuptake following excitatory neurotransmission. Insufficiency may therefore result in an exacerbated excitatory/inhibitory imbalance in neuronal signaling. Using a mouse model of AD that requires dietary ascorbate (Gulo-/-APPswe/PSEN1dE9), EEG was recorded at baseline and during 4 weeks of ascorbate depletion in young (5-month-old) and aged (20-month-old) animals. Data were scored for changes in quantity of spike trains, individual spikes, sleep-wake rhythms, sleep fragmentation, and brainwave power bands during light periods each week. We found an early increase in neuronal spike discharges with age and following ascorbate depletion in AD model mice and not controls, which did not correlate with brain amyloid load. Our data also show more sleep fragmentation with age and with ascorbate depletion. Additionally, changes in brain wave activity were observed within different vigilance states in both young and aged mice, where Gulo-/-APPswe/PSEN1dE9 mice had shifts towards higher frequency bands (alpha, beta, and gamma) and ascorbate depletion resulted in shifts towards lower frequency bands (delta and theta). Microarray data supported ascorbate insufficiency altering glutamatergic transmission through the decreased expression of glutamate related genes, however no changes in protein expression of glutamate reuptake transporters were observed. These data suggest that maintaining optimal brain ascorbate levels may support normal brain electrical activity and sleep patterns, particularly in AD patient populations where disruptions are observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDisease Models, AnimalElectroencephalographyAscorbic AcidGlutamic AcidMice, TransgenicAscorbic Acid DeficiencyAnimalsMiceBrainSignal TransductionMalePhenotype

Stichwörter der Autor:innen

Alzheimer's diseaseAscorbateEEGGlutamateMouseSeizureVitamin C

Substanzen

Ascorbic AcidGlutamic Acid

Autor:innen und Institutionen

  • Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, United States.
  • Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, United States; Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United S…

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Health Services Research and Development
  • NIEHS
  • Department of Veterans Affairs

Zitieren

APA

Buchanan, R. A., Wang, Y., May, J. M., & Harrison, F. E. (2024). Ascorbate insufficiency disrupts glutamatergic signaling and alters electroencephalogram phenotypes in a mouse model of Alzheimer's disease. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2024.106602

Vancouver

Buchanan RA, Wang Y, May JM, Harrison FE. Ascorbate insufficiency disrupts glutamatergic signaling and alters electroencephalogram phenotypes in a mouse model of Alzheimer's disease. Neurobiology of Disease. 2024. doi:10.1016/j.nbd.2024.106602

BibTeX
@article{Buchanan2024,
  author = {Buchanan, Rebecca A and Wang, Yuhan and May, James M and Harrison, Fiona E},
  title = {Ascorbate insufficiency disrupts glutamatergic signaling and alters electroencephalogram phenotypes in a mouse model of Alzheimer's disease},
  journal = {Neurobiology of Disease},
  year = {2024},
  doi = {10.1016/j.nbd.2024.106602}
}
Kostenlos starten →